Clinical studies that actually treated using iPS cells of patients with SCI.

The 6th , Nakamura, Associate Professor of Keio University ( orthopedics ) has announced plans to start in 2017 , a clinical study for the treatment of actually using the ( induced pluripotent stem cells ) iPS cells of patients with spinal cord injury .
I was presented at the Japanese Society for Regenerative Medicine held in Kyoto . Based on regenerative medicine safety method will be implemented this year , I want to apply for research in the country in '16 .
In spinal cord injury , central nervous system of the spine may be damaged , such as traffic accidents , limb can not be moved . Research team Okano university professor and associate professor of Nakamura ( physiology ) et al , plans were transplanted to the affected area neural stem cells from which the nerves made ​​from iPS cells , connecting the nerves interrupted .
In 2-4 weeks after the accident , the subject , 20 people before and after patients before the wound begins to mass inflammation in the affected area fits . Nerve cells to be transplanted in the 7 to 10 million units per patient , and that made ​​from iPS cells for regenerative medicine for Kyoto starts to provide research to institutions, such as universities at the end of this year . It is a good age for the patient to healing actually using the iPS cells toward the practical clinical research is on track has come early .


慶応大の中村准教授（整形外科学）は６日、脊髄損傷の患者をｉＰＳ細胞（人工多能性幹細胞）を使って実際に治療する臨床研究を、２０１７年度に始める計画を明らかにした。
　京都市で開かれた日本再生医療学会で発表した。今年施行される再生医療安全性確保法に基づき、１６年に国に研究内容を申請する。
　脊髄損傷では、交通事故などで背骨の中枢神経が傷つき、手足が動かせなくなる。中村准教授や岡野同大教授（生理学）らの研究チームは、ｉＰＳ細胞から作った神経の元になる神経幹細胞を患部に移植し、途切れた神経をつなげる計画だ。
　対象は、事故から２～４週間後で、患部の炎症が収まり傷口が固まり始める前の患者２０人前後。移植する神経細胞は患者１人につき７００万～１０００万個で、京都大が今年末にも大学などの研究機関へ提供を始める再生医療用のｉＰＳ細胞から作製するという。臨床研究が軌道に乗って実用化に向かいｉＰＳ細胞を使って実際に患者が治癒する時代が早く到来するといいですね。